Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial.
Roucher C, Brosius I, Mbow M, Faye BT, De Hondt A, Smekens B, Arango D, Burm C, Tsoumanis A, Paredis L, van Herrewege Y, Potters I, Cisse B, Mboup S, Polman K, Bottieau E. Roucher C, et al. Among authors: van herrewege y. BMJ Open. 2021 Jun 24;11(6):e047147. doi: 10.1136/bmjopen-2020-047147. BMJ Open. 2021. PMID: 34168029 Free PMC article.
Preexposure Intradermal Rabies Vaccination: A Noninferiority Trial in Healthy Adults on Shortening the Vaccination Schedule From 28 to 7 Days.
Soentjens P, Andries P, Aerssens A, Tsoumanis A, Ravinetto R, Heuninckx W, van Loen H, Brochier B, Van Gucht S, Van Damme P, Van Herrewege Y, Bottieau E. Soentjens P, et al. Among authors: van herrewege y, van damme p, van loen h, van gucht s. Clin Infect Dis. 2019 Feb 1;68(4):607-614. doi: 10.1093/cid/ciy513. Clin Infect Dis. 2019. PMID: 29939243 Clinical Trial.
Time of administration of rabies immunoglobulins and adequacy of antibody response upon post-exposure prophylaxis: a descriptive retrospective study in Belgium.
Soentjens P, Croughs M, Burm C, Declerq S, Clerinx J, Maniewski U, Van Den Broucke S, Theunissen C, Huits R, Brosius I, Florence E, Kenyon C, Van Griensven J, Van Ierssel S, Lynen L, Balliauw K, Van Gucht S, Van Esbroeck M, Vlieghe E, Bottieau E, Van Herrewege Y. Soentjens P, et al. Among authors: van herrewege y. Acta Clin Belg. 2021 Apr;76(2):91-97. doi: 10.1080/17843286.2019.1662993. Epub 2019 Sep 4. Acta Clin Belg. 2021. PMID: 31483218
Vaccinating children in high-endemic rabies regions: what are we waiting for?
Soentjens P, Berens-Riha N, Van Herrewege Y, Van Damme P, Bottieau E, Ravinetto R. Soentjens P, et al. Among authors: van herrewege y. BMJ Glob Health. 2021 Feb;6(2):e004074. doi: 10.1136/bmjgh-2020-004074. BMJ Glob Health. 2021. PMID: 33568394 Free PMC article. No abstract available.
Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial.
Van Dijck C, Tsoumanis A, Rotsaert A, Vuylsteke B, Van den Bossche D, Paeleman E, De Baetselier I, Brosius I, Laumen J, Buyze J, Wouters K, Lynen L, Van Esbroeck M, Herssens N, Abdellati S, Declercq S, Reyniers T, Van Herrewege Y, Florence E, Kenyon C. Van Dijck C, et al. Among authors: van herrewege y. Lancet Infect Dis. 2021 May;21(5):657-667. doi: 10.1016/S1473-3099(20)30778-7. Epub 2021 Mar 4. Lancet Infect Dis. 2021. PMID: 33676596 Clinical Trial.
Five accelerated schedules for the tick-borne encephalitis vaccine FSME-Immun® in last-minute travellers: an open-label, single-Centre, randomized controlled pilot trial.
Berens-Riha N, Andries P, Aerssens A, Ledure Q, Vanderbeken Y, Heyndrickx L, Genbrugge E, Tsoumanis A, Van Herrewege Y, Ariën KK, Van Innis M, Vanbrabant P, Soentjens P; FASTBEPROTECT Research Team. Berens-Riha N, et al. Among authors: van herrewege y. J Travel Med. 2023 Apr 19:taad053. doi: 10.1093/jtm/taad053. Online ahead of print. J Travel Med. 2023. PMID: 37074147
A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides.
Van Herrewege Y, Michiels J, Waeytens A, De Boeck G, Salden E, Heyndrickx L, van den Mooter G, de Béthune MP, Andries K, Lewi P, Praet M, Vanham G. Van Herrewege Y, et al. Among authors: van den mooter g. Antiviral Res. 2007 May;74(2):111-24. doi: 10.1016/j.antiviral.2006.10.010. Epub 2006 Nov 7. Antiviral Res. 2007. PMID: 17097156
25 results